ScreenerHero
GENTGentian Diagnostics AS
OSL · NO · Healthcare · Medical Devices · gentian.com
38.80NOK+3.19%Mkt Cap: 56.07M $P/E: —

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemi…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$203.17BUSDP/E 37.7
SYK
Stryker Corporation
$126.37BUSDP/E 34.2
MDT
Medtronic plc
$119.49BUSDP/E 25.0
BSX
Boston Scientific Corporation
$73.00BUSDP/E 20.4
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
EW
Edwards Lifesciences Corporation
$51.70BUSDP/E 53.4
DXCM
DexCom, Inc.
$34.85BUSDP/E 36.5
GEHC
GE HealthCare Technologies Inc. Common Stock
$34.04BUSDP/E 17.2
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
PHG
Koninklijke Philips N.V.
$26.80BUSDP/E 20.8
STE
STERIS plc
$23.20BUSDP/E 29.1
ZBH
Zimmer Biomet Holdings, Inc.
$19.26BUSDP/E 24.5
PEN
Penumbra, Inc.
$12.81BUSDP/E 79.7
SNN
Smith & Nephew plc
$12.25BUSDP/E 19.9
SN
Smith & Nephew plc
$11.48BUSDP/E 19.8
GMED
Globus Medical, Inc.
$11.67BUSDP/E 22.2
GKOS
Glaukos Corp
$10.91BUSD
EUZ
Eckert & Ziegler Strahlen-und Medizinte AG
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.28BUSDP/E 27.5
BIO
Bio-Rad Laboratories, Inc. Class A
$10.17BUSDP/E 46.3

Key Statistics

Company
Market Cap56.07M $
Enterprise Value48.49M $
Revenue (TTM)17.02M $
Gross Profit9.18M $
Net Income (TTM)1.24M $
Revenue/Share1.103 USD
Last Price38.80 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees63
CountryNO
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)15.04
PEG—
EV/EBITDA20.03
EV/Revenue2.85
P/S3.29
P/B3.28
EPS (TTM)-0.55
EPS (Forward)2.58
52W Range
33.5020% of range60.00
52W High60.00 NOK
52W Low33.50 NOK
Profitability
Gross Margin55.64%
Oper. Margin11.88%
EBITDA Margin14.22%
Profit Margin7.51%
ROE6.47%
ROA5.13%
Growth
Revenue Growth14.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.98M $
CapEx (TTM)1.01M $
FCF Margin0.79%
FCF Yield0.24%
Net Debt-5.85M $
Net Debt/EBITDA-2.41
Balance Sheet
Debt/Equity0.11
Current Ratio7.43
Quick Ratio5.20
Book Value/Sh11.82 NOK
Cash/Share5.132 NOK
Dividends
Fwd Div Rate0.6000 NOK
Trail. Div Rate0.6000 NOK
Div. Yield1.54%
5Y Avg Yield—
Payout Ratio46.51%
Ex-Div DateMay 6, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)60.00 NOK
Upside (mean)+54.6%
Target Range60.00 NOK – 60.00 NOK
# Analysts1
Ownership
Shares Out.15.46M
Float7.28M
Insiders44.62%
Institutions40.11%
Technical
SMA 5038.10 (+1.8%)
SMA 20045.04 (-13.8%)
Beta0.45
S&P 52W Chg18.16%
Avg Vol (30d)3.86K
Avg Vol (10d)2.35K
Technical Indicators
RSI (14)49.8
MACD0.0654
MACD Signal0.3209
MACD Hist.-0.2554
BB Upper41.26 NOK
BB Middle39.35 NOK
BB Lower37.45 NOK
BB Width9.67%
ATR (14)1.515 NOK
Vol Ratio (20d)0.26x